{"schema_version":"1","generated_at":"2026-11-06T06:06:54.013Z","data_as_of":null,"url":"https://www.findmykol.com/kol/paul-becherer","json_url":"https://www.findmykol.com/kol/paul-becherer/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"paul-becherer","name":"Paul Becherer","credential":"MD","specialty":"Infectious Disease","specialty_raw":"Infectious Disease","therapeutic_area":"Infectious Disease","therapeutic_areas":["Infectious Disease"],"city":"Raleigh","state":"NC","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1962464719","openalex":"A5047079215"},"summary":"Paul Becherer is an Infectious Disease physician. OpenAlex indexes 33 publications with 1,228 citations (h-index 16).","overview":null,"focus":{"indications":[],"research_topics":["Infectious Disease"]},"scholarship":{"works_count":33,"cited_by_count":1228,"h_index":16,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":2,"shown":2,"withheld":0,"rows":[{"payer":"Insmed, Inc.","program_year":2025,"amount_usd":18.14,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1962464719"},{"payer":"Gilead Sciences, Inc.","program_year":2021,"amount_usd":11.92,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1962464719"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1962464719","source":"payments"},"publications":{"total":33,"shown":5,"withheld":28,"matched_by":"OpenAlex author record","recent":[{"title":"The use of 3.15% chlorhexidine gluconate/70% alcohol hub disinfection to prevent central line-associated bloodstream infections in dialysis patients","year":2020,"journal":"British Journal of Nursing","source_url":"https://doi.org/10.12968/bjon.2020.29.2.s24","status":"verified"},{"title":"The Use of 3.15% Chlorhexidine Gluconate/70% Alcohol Hub Disinfection to Prevent Central Line-Associated Bloodstream Infections in Dialysis Patients","year":2019,"journal":"Journal of the Association for Vascular Access","source_url":"https://doi.org/10.2309/j.java.2019.004.001","status":"verified"},{"title":"Effectiveness of targeted enhanced terminal room disinfection on hospital-wide acquisition and infection with multidrug-resistant organisms and Clostridium difficile: a secondary analysis of a multicentre cluster randomised controlled trial with crossover design (BETR Disinfection)","year":2018,"journal":"The Lancet Infectious Diseases","source_url":"https://doi.org/10.1016/s1473-3099(18)30278-0","status":"verified"},{"title":"The Effectiveness of 3.15% Chlorhexidine Gluconate/70% Alcohol Hub Disinfection to Prevent Central Line-Associated Blood Stream Infections","year":2018,"journal":"American Journal of Infection Control","source_url":"https://doi.org/10.1016/j.ajic.2018.04.161","status":"verified"},{"title":"Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection study): a cluster-randomised, multicentre, crossover study","year":2017,"journal":"The Lancet","source_url":"https://doi.org/10.1016/s0140-6736(16)31588-4","status":"verified"}],"source":"works"},"contact":{"address_1":"2304 WESVILL CT","address_2":"SUITE 240","city":"Raleigh","state":"NC","zip":"276072973","phone":"919-571-1567","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1962464719","source":"identity"},"similar":[{"name":"Thomas Walsh","slug":"thomas-walsh","institution":"Cornell University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/thomas-walsh","json_url":"https://www.findmykol.com/kol/thomas-walsh/profile.json"},{"name":"Douglas Richman","slug":"douglas-richman","institution":"University of California San Diego","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/douglas-richman","json_url":"https://www.findmykol.com/kol/douglas-richman/profile.json"},{"name":"Henry Masur","slug":"henry-masur","institution":"National Institutes of Health","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/henry-masur","json_url":"https://www.findmykol.com/kol/henry-masur/profile.json"},{"name":"Vance Fowler","slug":"vance-fowler","institution":"Duke University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/vance-fowler","json_url":"https://www.findmykol.com/kol/vance-fowler/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":28}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2023-10-12","provider_certified":"2023-10-12","collected_at":"2026-11-05T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}